Thrombosis and Haemostasis

LinksSchließen

Referenz

Ohman EM, Roe MT, Steg PG. , et al.
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.

Lancet 2017;
389 (10081): 1799-1808

Bibliographische Angaben herunterladen

Aufrufen in: